Base de dados : MEDLINE
Pesquisa : C13.703.844.506.389 [Categoria DeCS]
Referências encontradas : 1501 [refinar]
Mostrando: 1 .. 10   no formato [Detalhado]

página 1 de 151 ir para página                         

  1 / 1501 MEDLINE  
              next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28904704
[Au] Autor:Barka I; Dendana E; Chikhrouhou N; Maroufi A; Kacem M; Chadli M; Ach K
[Ad] Endereço:Service d'Endocrinologie, CHU Farhat Hached de Sousse, Tunisie.
[Ti] Título:[Prolactin-secreting microadenoma in menopausal women].
[Ti] Título:Micro adénome à prolactine à l'âge de la ménopause..
[So] Source:Pan Afr Med J;27:177, 2017.
[Is] ISSN:1937-8688
[Cp] País de publicação:Uganda
[La] Idioma:fre
[Ab] Resumo:Prolactin-secreting adenoma is rare in elderly women. Patient's clinical picture may be confused with that of menopause, making diagnosis sometimes difficult. We report the case of a 57-year old woman with a 2-year history of secondary amenorrhea without hot flushes associated with galactorrhea in order to highlight the peculiarities of prolactin-secreting microadenomas. Physical examination confirmed the diagnosis of galactorrhoea and biology showed hyperprolactinemia at mIU/L, FSH = 15.1 IU/L and LH = 4,1 IU/L. Pituitary MRI showed left adenoma measuring 8 mm. Patient's evolution under dopaminergic treatment was marked by the recovery, for a transitional period, of mestrual cycles and the occurrence of hot flushes, normalization of prolactin levels and reduction of adenoma size.
[Mh] Termos MeSH primário: Adenoma/diagnóstico por imagem
Neoplasias Hipofisárias/diagnóstico por imagem
Prolactina/secreção
Prolactinoma/diagnóstico por imagem
[Mh] Termos MeSH secundário: Adenoma/patologia
Adenoma/terapia
Amenorreia/diagnóstico
Amenorreia/etiologia
Feminino
Galactorreia/diagnóstico
Galactorreia/etiologia
Seres Humanos
Hiperprolactinemia/etiologia
Imagem por Ressonância Magnética
Menopausa
Meia-Idade
Neoplasias Hipofisárias/patologia
Neoplasias Hipofisárias/terapia
Prolactinoma/patologia
Prolactinoma/terapia
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE
[Nm] Nome de substância:
9002-62-4 (Prolactin)
[Em] Mês de entrada:1709
[Cu] Atualização por classe:170925
[Lr] Data última revisão:
170925
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170915
[St] Status:MEDLINE
[do] DOI:10.11604/pamj.2017.27.177.11677


  2 / 1501 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28056181
[Au] Autor:Flores-Antón B; García-Lara NR; Pallás-Alonso CR
[Ad] Endereço:1 Hospital 12 de Octubre, Madrid, Spain.
[Ti] Título:An Adoptive Mother Who Became a Human Milk Donor.
[So] Source:J Hum Lact;33(2):419-421, 2017 May.
[Is] ISSN:1552-5732
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Inducing lactation in the absence of pregnancy (nonpuerperal lactation) is not always successful and, in many cases, only partial breastfeeding is achieved. Different protocols have been described, but scientific evidence and research are lacking in this area. The authors describe the case of a woman with a history of a miscarriage, for whom the lactation induction process was so effective that she became a milk donor even before she received her adopted child. She had not previously used hormone treatment. She was given domperidone as a galactogogue for 1 month. The pumping protocol began with a double electric breast pump combined with manual pumping 6 months before her child was delivered, and 3 months later, she was accepted as a donor by our milk bank. This highlights the importance of regular stimulation as a milk production mechanism. This is the first case of human milk donation in an adoptive mother described in the literature.
[Mh] Termos MeSH primário: Adoção/psicologia
Amenorreia/patologia
Galactorreia/patologia
Leite Humano/metabolismo
Mães/psicologia
Doadores de Tecidos/psicologia
[Mh] Termos MeSH secundário: Adulto
Amenorreia/psicologia
Aleitamento Materno/métodos
Aleitamento Materno/psicologia
Feminino
Galactorreia/psicologia
Seres Humanos
Infertilidade/etiologia
Lactação/metabolismo
Lactação/fisiologia
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1710
[Cu] Atualização por classe:171002
[Lr] Data última revisão:
171002
[Sb] Subgrupo de revista:N
[Da] Data de entrada para processamento:170106
[St] Status:MEDLINE
[do] DOI:10.1177/0890334416682007


  3 / 1501 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:27926659
[Au] Autor:Lambert K; Rees K; Seed PT; Dhanjal MK; Knight M; McCance DR; Williamson C
[Ad] Endereço:Royal Hampshire County Hospital, Winchester, Hampshire, the Division of Women's Health, King's College London and Queen Charlotte's and Chelsea Hospital, Imperial College Healthcare National Health Service Trust, London, the National Perinatal Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, and the Regional Centre for Endocrinology and Diabetes, Royal Victoria Hospital, Belfast, Northern Ireland, United Kingdom.
[Ti] Título:Macroprolactinomas and Nonfunctioning Pituitary Adenomas and Pregnancy Outcomes.
[So] Source:Obstet Gynecol;129(1):185-194, 2017 Jan.
[Is] ISSN:1873-233X
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:OBJECTIVE: To examine the monitoring, management, and outcomes of pituitary tumors in pregnancy. METHODS: A national, prospective, observational, population-based case series study was conducted in all U.K. consultant-led obstetric units over 3 years using the U.K. Obstetric Surveillance System. To evaluate rates of adverse pregnancy outcomes, women with a macroprolactinoma (10 mm or greater) or nonfunctioning pituitary adenoma, diagnosed before or during pregnancy, were compared with two comparison groups: 1) a U.K. Obstetric Surveillance System cohort with singleton (n=2,205) or twin (n=27) pregnancy; and 2) data from the Office of National Statistics (n=2,703,102). Main outcome measures were the incidence, management, and frequency of adverse maternal and offspring outcomes of pituitary tumors in pregnancy. RESULTS: There were 71 confirmed cases of pituitary tumors in pregnancy (49 macrolactinoma, 16 nonfunctioning adenomas, three acromegaly, three Cushing's disease). The women with pituitary tumors were 4 years older than comparison women (P<.001). None of the nine women treated with surgery or radiotherapy before pregnancy had symptomatic tumor expansion. This occurred in 6 of 40 women with macroprolactinomas and one of seven nonfunctioning adenomas diagnosed before conception and in three of five women with nonfunctioning adenomas diagnosed in pregnancy. Two women had pituitary apoplexy, both of whom also had symptoms of expansion of tumor or surrounding pituitary tissue. To within the level of accuracy possible, there was no evidence that pituitary tumors were associated with adverse pregnancy outcomes (pregnancy-induced hypertension, preeclampsia, preterm labor, stillbirth). Women with nonfunctioning adenomas were more likely to have cesarean delivery compared with women in a control group (relative risk 2.06, confidence interval 1.26-3.36, P=.035). CONCLUSION: The majority of women with macroprolactinomas and nonfunctioning adenomas have good pregnancy outcomes. Nonfunctioning pituitary adenomas occur more commonly in pregnancy than previously thought and can present de novo with symptoms of pituitary expansion in pregnancy.
[Mh] Termos MeSH primário: Adenoma/epidemiologia
Neoplasias Hipofisárias/epidemiologia
Complicações Neoplásicas na Gravidez/epidemiologia
Prolactinoma/epidemiologia
[Mh] Termos MeSH secundário: Adenoma/complicações
Adenoma/patologia
Adenoma/terapia
Adulto
Amenorreia/etiologia
Antineoplásicos/uso terapêutico
Bromocriptina/uso terapêutico
Estudos de Casos e Controles
Cesárea/estatística & dados numéricos
Agonistas de Dopamina/uso terapêutico
Ergolinas/uso terapêutico
Feminino
Galactorreia/etiologia
Seres Humanos
Incidência
Neoplasias Hipofisárias/complicações
Neoplasias Hipofisárias/patologia
Neoplasias Hipofisárias/terapia
Pré-Eclâmpsia/epidemiologia
Cuidado Pré-Concepcional
Gravidez
Complicações Neoplásicas na Gravidez/patologia
Complicações Neoplásicas na Gravidez/terapia
Nascimento Prematuro/epidemiologia
Prolactinoma/complicações
Prolactinoma/patologia
Prolactinoma/terapia
Estudos Prospectivos
Natimorto/epidemiologia
Reino Unido/epidemiologia
Transtornos da Visão/etiologia
Adulto Jovem
[Pt] Tipo de publicação:JOURNAL ARTICLE; OBSERVATIONAL STUDY
[Nm] Nome de substância:
0 (Antineoplastic Agents); 0 (Dopamine Agonists); 0 (Ergolines); 3A64E3G5ZO (Bromocriptine); LL60K9J05T (cabergoline)
[Em] Mês de entrada:1706
[Cu] Atualização por classe:170614
[Lr] Data última revisão:
170614
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:161208
[St] Status:MEDLINE
[do] DOI:10.1097/AOG.0000000000001747


  4 / 1501 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
[PMID]:27820136
[Au] Autor:Grimes A; Mirkheshti N; Chatterjee B; Tomlinson G; Assanasen C
[Ad] Endereço:Departments of *Pediatrics, Hematology/Oncology ‡Molecular Medicine, UT Health Science Center San Antonio †Greehey Children's Cancer Research Institute §Texas Research Park, San Antonio, TX ∥Dept of Hematology/Oncology, University of Maryland Greenebaum Cancer Center, Baltimore, MD.
[Ti] Título:Paraneoplastic Galactorrhea in Childhood T-ALL: An Evaluation of Tumor-derived Prolactin.
[So] Source:J Pediatr Hematol Oncol;39(1):e18-e20, 2017 Jan.
[Is] ISSN:1536-3678
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:T-cell acute lymphoblastic leukemia (T-ALL) comprises 15% of childhood leukemia. Although multiagent pulse chemotherapy has improved event-free survival in recent decades, the lack of reliable prognosticators and high rate of relapse remain a challenge. Described is a novel discovery of tumor-derived hyperprolactinemia in childhood T-ALL through a case associated with paraneoplastic galactorrhea. Prolactin production by tumor cells, although a rare phenomenon, is previously demonstrated in several adult cancers and 2 pediatric malignancies with unknown implications. This is the first report demonstrating tumor-derived prolactin in pediatric T-ALL and offers potential as a disease marker and therapeutic drug target.
[Mh] Termos MeSH primário: Galactorreia/etiologia
Síndromes Endócrinas Paraneoplásicas/etiologia
Leucemia-Linfoma Linfoblástico de Células T Precursoras/complicações
Prolactina/sangue
[Mh] Termos MeSH secundário: Adolescente
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico
Artralgia/etiologia
Asparaginase/administração & dosagem
Deleção Cromossômica
Doxorrubicina/administração & dosagem
Fadiga/etiologia
Feminino
Galactorreia/sangue
Deleção de Genes
Seres Humanos
Síndromes Endócrinas Paraneoplásicas/sangue
Polietilenoglicóis/administração & dosagem
Leucemia-Linfoma Linfoblástico de Células T Precursoras/diagnóstico
Leucemia-Linfoma Linfoblástico de Células T Precursoras/tratamento farmacológico
Leucemia-Linfoma Linfoblástico de Células T Precursoras/genética
Prednisona/administração & dosagem
Proteínas Proto-Oncogênicas c-ets/genética
Indução de Remissão
Proteínas Repressoras/genética
Vincristina/administração & dosagem
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE
[Nm] Nome de substância:
0 (ETS translocation variant 6 protein); 0 (Proto-Oncogene Proteins c-ets); 0 (Repressor Proteins); 30IQX730WE (Polyethylene Glycols); 5J49Q6B70F (Vincristine); 7D96IR0PPM (pegaspargase); 80168379AG (Doxorubicin); 9002-62-4 (Prolactin); EC 3.5.1.1 (Asparaginase); VB0R961HZT (Prednisone)
[Em] Mês de entrada:1709
[Cu] Atualização por classe:170904
[Lr] Data última revisão:
170904
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:161108
[St] Status:MEDLINE


  5 / 1501 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:27671881
[Au] Autor:Zaidi HA; Cote DJ; Castlen JP; Burke WT; Liu YH; Smith TR; Laws ER
[Ad] Endereço:Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Electronic address: hzaidi@partners.org.
[Ti] Título:Time Course of Resolution of Hyperprolactinemia After Transsphenoidal Surgery Among Patients Presenting with Pituitary Stalk Compression.
[So] Source:World Neurosurg;97:2-7, 2017 Jan.
[Is] ISSN:1878-8769
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:BACKGROUND: Primary lactotroph disinhibition, or stalk effect, occurs when mechanical compression of the pituitary stalk disrupts the tonic inhibition by dopamine released by the hypothalamus. The resolution of pituitary stalk effect-related hyperprolactinemia postoperatively has not been studied in a large cohort of patients. We performed a retrospective review to investigate the time course of recovery of lactotroph disinhibition after transsphenoidal surgery. METHODS: Medical records were retrospectively reviewed for all patients undergoing transsphenoidal surgery with the senior author from April 2008 to November 2014. RESULTS: Of 556 pituitary adenomas, 289 (52.0%) were eliminated: 77 (13.9%) had an immunohistochemically confirmed prolactinoma, 119 (21.4%) patients had previous surgery, 93 (16.7%) had incomplete medical records, leaving 267 patients (48.0%) for final analysis. Of these patients, 72 (27.0%) had increased serum prolactin levels (≥23.3 ng/mL), suggestive of pituitary stalk effect (maximum prolactin level = 148.0 ng/mL). Patients with stalk effect were more likely than those with normal serum prolactin levels to present with menstrual dysfunction (29.7% vs. 19.4%; P < 0.01) and galactorrhea (11.1% vs. 2.1%; P < 0.01). Patients with lactotroph disinhibition were more likely to harbor macroadenomas than were patients who did not show lactotroph disinhibition (81.9% vs. 70.2%; P = 0.06). Among patients with increased preoperative prolactin, 77.8% experienced normalization of serum prolactin postoperatively, galactorrhea improved in 100%, sexual dysfunction resolved in 66.6%, and menstrual dysfunction among premenopausal females normalized in 73.3% at last follow-up (mean, 5.35 years; range, 0.1-10 years). CONCLUSIONS: Transsphenoidal surgery can provide durable normalization of serum prolactin levels and related symptoms caused by pituitary stalk compression-related lactotroph disinhibition.
[Mh] Termos MeSH primário: Hiperprolactinemia/cirurgia
Procedimentos Neurocirúrgicos/métodos
Hipófise/cirurgia
Neoplasias Hipofisárias/complicações
Prolactinoma/complicações
[Mh] Termos MeSH secundário: Adolescente
Adulto
Idoso
Idoso de 80 Anos ou mais
Estudos de Coortes
Feminino
Galactorreia/etiologia
Galactorreia/cirurgia
Seres Humanos
Hiperprolactinemia/sangue
Masculino
Meia-Idade
Nariz/cirurgia
Neoplasias Hipofisárias/cirurgia
Gravidez
Prolactina/sangue
Prolactinoma/cirurgia
Reoperação/métodos
Osso Esfenoide/cirurgia
Resultado do Tratamento
Adulto Jovem
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
9002-62-4 (Prolactin)
[Em] Mês de entrada:1709
[Cu] Atualização por classe:170913
[Lr] Data última revisão:
170913
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:160928
[St] Status:MEDLINE


  6 / 1501 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:27659384
[Au] Autor:Wheble G; Taylor KJ; Potter M
[Ad] Endereço:Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital , Oxfordx , UK.
[Ti] Título:Galactorrhoea of the neck following pectoralis major reconstruction of a pharyngeal defect.
[So] Source:Ann R Coll Surg Engl;99(1):e38-e39, 2017 Jan.
[Is] ISSN:1478-7083
[Cp] País de publicação:England
[La] Idioma:eng
[Ab] Resumo:We describe a case of postoperative galactorrhea following the use of a pedicled pectoralis major myocutaneous flap for reconstruction of a pharyngolaryngeal defect in a woman with squamous cell carcinoma. We believe this to be unique in the literature, and an important complication to be reported, due to the similarities in appearance of galactorrhoea and postoperative aerodigestive tract/cutaneous fistula.
[Mh] Termos MeSH primário: Galactorreia/etiologia
Retalhos Cirúrgicos/efeitos adversos
[Mh] Termos MeSH secundário: Idoso
Carcinoma de Células Escamosas/cirurgia
Feminino
Galactorreia/diagnóstico por imagem
Seres Humanos
Neoplasias Laríngeas/cirurgia
Esvaziamento Cervical/efeitos adversos
Recidiva Local de Neoplasia/cirurgia
Músculos Peitorais/transplante
Neoplasias Faríngeas/cirurgia
Complicações Pós-Operatórias/etiologia
Tomografia Computadorizada por Raios X
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE
[Em] Mês de entrada:1702
[Cu] Atualização por classe:170428
[Lr] Data última revisão:
170428
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:160924
[St] Status:MEDLINE
[do] DOI:10.1308/rcsann.2016.0294


  7 / 1501 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
[PMID]:27438185
[Au] Autor:Türkoglu S
[Ad] Endereço:Department of Child and Adolescent Psychiatry, Selcuk University Faculty of Medicine, Konya, Turkey.
[Ti] Título:Citalopram-Induced Galactorrhea in an Adolescent.
[So] Source:Clin Neuropharmacol;39(6):331, 2016 Nov/Dec.
[Is] ISSN:1537-162X
[Cp] País de publicação:United States
[La] Idioma:eng
[Mh] Termos MeSH primário: Citalopram/efeitos adversos
Galactorreia/induzido quimicamente
Inibidores da Captação de Serotonina/efeitos adversos
[Mh] Termos MeSH secundário: Adolescente
Depressão/tratamento farmacológico
Feminino
Seres Humanos
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Serotonin Uptake Inhibitors); 0DHU5B8D6V (Citalopram)
[Em] Mês de entrada:1701
[Cu] Atualização por classe:170123
[Lr] Data última revisão:
170123
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:160721
[St] Status:MEDLINE


  8 / 1501 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:27219091
[Au] Autor:Warren MB
[Ad] Endereço:University of Washington Department of Psychiatry and Behavioral Sciences Boise Veterans Administration Medical Center 500 W. Fort St., Boise, ID mark.warren@va.gov.
[Ti] Título:Venlafaxine-Associated Euprolactinemic Galactorrhea and Hypersexuality: A Case Report and Review of the Literature.
[So] Source:J Clin Psychopharmacol;36(4):399-400, 2016 Aug.
[Is] ISSN:1533-712X
[Cp] País de publicação:United States
[La] Idioma:eng
[Mh] Termos MeSH primário: Transtornos de Ansiedade/tratamento farmacológico
Transtorno Depressivo/tratamento farmacológico
Galactorreia/induzido quimicamente
Inibidores da Recaptação de Serotonina e Norepinefrina/efeitos adversos
Disfunções Sexuais Fisiológicas/induzido quimicamente
Cloridrato de Venlafaxina/efeitos adversos
[Mh] Termos MeSH secundário: Adulto
Feminino
Seres Humanos
[Pt] Tipo de publicação:CASE REPORTS; LETTER; REVIEW
[Nm] Nome de substância:
0 (Serotonin and Noradrenaline Reuptake Inhibitors); 7D7RX5A8MO (Venlafaxine Hydrochloride)
[Em] Mês de entrada:1704
[Cu] Atualização por classe:170412
[Lr] Data última revisão:
170412
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:160525
[St] Status:MEDLINE
[do] DOI:10.1097/JCP.0000000000000514


  9 / 1501 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:27138902
[Au] Autor:Shimon I; Sosa E; Mendoza V; Greenman Y; Tirosh A; Espinosa E; Popovic V; Glezer A; Bronstein MD; Mercado M
[Ad] Endereço:Institute of Endocrinology, Beilinson Hospital, Rabin Medical Center, 49100, Petah Tikva, Israel. ilanshi@clalit.org.il.
[Ti] Título:Giant prolactinomas larger than 60 mm in size: a cohort of massive and aggressive prolactin-secreting pituitary adenomas.
[So] Source:Pituitary;19(4):429-36, 2016 Aug.
[Is] ISSN:1573-7403
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:OBJECTIVES: Prolactin (PRL)-secreting macroadenomas usually measure between 10 and 40 mm. Giant (adenoma size ≥40 mm) PRL-tumors are not common, and larger prolactinomas (maximal diameter ≥60 mm) are rare, and their management outcomes have not been well characterized. METHODS: We have identified 18 subjects (16 men, 2 females) with giant PRL-adenomas (size ≥60 mm; PRL > 1000 ng/ml) and summarized their characteristics and response to treatment. RESULTS: Mean age was 36.3 ± 13.5 years (range 12-59 years). Mean adenoma size was 71.8 ± 10.2 mm (60-92 mm). Complaints at presentation included headaches in 11 patients, visual deterioration in 9, sexual dysfunction in 9 males, and behavioral changes in two. Fourteen (78 %) had visual field defects. Mean PRL at presentation was 28,465 ng/ml (range 1300-270,000). All patients were treated with cabergoline (3.9 ± 2.0 mg/week), except for one who received bromocriptine. Treatment achieved PRL normalization in 11/18 patients within a median interval of 20 months. Visual improvement occurred in 12/14 patients with pre-treatment visual abnormalities. Nine patients underwent surgery (transsphenoidal, 7; transcranial, 2). None of the seven patients with elevated PRL before surgery achieved remission post-operatively. After a follow-up of 7.8 ± 5.1 years, 15/18 patients had significant adenoma shrinkage. Eleven patients are normoprolactinemic, 3 are partially controlled (PRL < 3 × ULN), and 4 remain with significantly elevated PRL. Most patients reported disappearance or improvement of their complaints. CONCLUSIONS: These enormous PRL-adenomas are invasive but respond fairly well to medical treatment. Long-term therapy with high dose cabergoline together with a pituitary surgery in some patients was the key for their successful management, achieving biochemical and clinical remission in most patients.
[Mh] Termos MeSH primário: Neoplasias Hipofisárias/patologia
Prolactinoma/patologia
Carga Tumoral
[Mh] Termos MeSH secundário: Adolescente
Adulto
Antineoplásicos/uso terapêutico
Bromocriptina/uso terapêutico
Criança
Ergolinas/uso terapêutico
Feminino
Galactorreia/etiologia
Cefaleia/etiologia
Antagonistas de Hormônios/uso terapêutico
Seres Humanos
Masculino
Meia-Idade
Procedimentos Neurocirúrgicos
Neoplasias Hipofisárias/complicações
Neoplasias Hipofisárias/terapia
Prolactinoma/complicações
Prolactinoma/terapia
Disfunções Sexuais Fisiológicas/etiologia
Resultado do Tratamento
Transtornos da Visão/etiologia
Adulto Jovem
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Antineoplastic Agents); 0 (Ergolines); 0 (Hormone Antagonists); 3A64E3G5ZO (Bromocriptine); LL60K9J05T (cabergoline)
[Em] Mês de entrada:1703
[Cu] Atualização por classe:171031
[Lr] Data última revisão:
171031
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:160504
[St] Status:MEDLINE
[do] DOI:10.1007/s11102-016-0723-4


  10 / 1501 MEDLINE  
              first record previous record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:26769886
[Au] Autor:Trimeloni L; Spencer J
[Ad] Endereço:From the Conemaugh Family Medicine Residency Program, Johnstown, PA.
[Ti] Título:Diagnosis and Management of Breast Milk Oversupply.
[So] Source:J Am Board Fam Med;29(1):139-42, 2016 Jan-Feb.
[Is] ISSN:1558-7118
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Managing breastfeeding problems is an essential part of newborn care. While much is written on breast milk undersupply, little is written on oversupply, sometimes known as hyperlactation or hypergalactia. Infants of mothers with oversupply may have increased or decreased weight gain. Some may have large, frothy stools. They may develop a disordered latch. Mothers may report overly full, leaking breasts. Thyroid function should be assessed. Treatment is mostly anecdotal and includes methods to maintain breast fullness, such as block feedings. Pseudoephedrine and oral contraceptive pills may decrease the supply. Dopamine agonists such as carbergoline can be used as a last resort.
[Mh] Termos MeSH primário: Aleitamento Materno/métodos
Galactorreia/terapia
Hiperprolactinemia/complicações
Leite Humano
[Mh] Termos MeSH secundário: Anti-Inflamatórios não Esteroides/uso terapêutico
Aleitamento Materno/efeitos adversos
Diagnóstico Diferencial
Feminino
Galactorreia/diagnóstico
Galactorreia/etiologia
Seres Humanos
Hiperprolactinemia/sangue
Lactente
Recém-Nascido
Fitoterapia
Plantas Medicinais
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Nm] Nome de substância:
0 (Anti-Inflammatory Agents, Non-Steroidal)
[Em] Mês de entrada:1612
[Cu] Atualização por classe:161230
[Lr] Data última revisão:
161230
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:160116
[St] Status:MEDLINE
[do] DOI:10.3122/jabfm.2016.01.150164



página 1 de 151 ir para página                         
   


Refinar a pesquisa
  Base de dados : MEDLINE Formulário avançado   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/OPAS/OMS - Centro Latino-Americano e do Caribe de Informação em Ciências da Saúde